Supraventricular Tachycardia (SVT) is a cardiovascular condition marked by an excessively rapid heartbeat originating above the heart's ventricles. The underlying cause often involves abnormal electrical pathways within the heart, leading to rapid and irregular contractions. Individuals experiencing SVT may encounter fleeting or extended episodes, accompanied by symptoms such as palpitations, dizziness, and breathlessness. Though not typically life-threatening, SVT can substantially disrupt daily life and impact overall well-being. Addressing SVT may involve various approaches, from lifestyle adjustments and pharmaceutical interventions to more invasive procedures like catheter ablation, which aims to restore a normal heart rhythm. Accurate diagnosis and effective management are pivotal in alleviating symptoms and preventing potential complications associated with this prevalent cardiac arrhythmia.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Post-cardiotomy ECMO (PC-ECMO)
Gustavo Lionel Knop, Mayo Clinic, United States
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom